Literature DB >> 2109509

Comparison of endothelin-1 and -3 on models of inflammation.

C L Chander1, D W Howat, A R Moore, P R Colville-Nash, F M Desa, P Braquet, D A Willoughby.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1990        PMID： 2109509     DOI： 10.1007/bf01964710

Source DB:  PubMed          Journal:  Agents Actions        ISSN： 0065-4299


× No keyword cloud information.
  5 in total

1.  Primary structure, synthesis, and biological activity of rat endothelin, an endothelium-derived vasoconstrictor peptide.

Authors:  M Yanagisawa; A Inoue; T Ishikawa; Y Kasuya; S Kimura; S Kumagaye; K Nakajima; T X Watanabe; S Sakakibara; K Goto
Journal:  Proc Natl Acad Sci U S A       Date:  1988-09       Impact factor: 11.205

2.  A novel potent vasoconstrictor peptide produced by vascular endothelial cells.

Authors:  M Yanagisawa; H Kurihara; S Kimura; Y Tomobe; M Kobayashi; Y Mitsui; Y Yazaki; K Goto; T Masaki
Journal:  Nature       Date:  1988-03-31       Impact factor: 49.962

3.  Inflammation in healing. 1. Time-course and mediation of exudation in wound healing in the rat.

Authors:  A W Lykke; R Cummings
Journal:  Br J Exp Pathol       Date:  1969-06

4.  The local modulation of vascular permeability by endothelial cell derived products.

Authors:  C L Chander; A R Moore; F M Desa; D Howat; D A Willoughby
Journal:  J Pharm Pharmacol       Date:  1988-10       Impact factor: 3.765

5.  Pressor effects of circulating endothelin are limited by its removal in the pulmonary circulation and by the release of prostacyclin and endothelium-derived relaxing factor.

Authors:  G de Nucci; R Thomas; P D'Orleans-Juste; E Antunes; C Walder; T D Warner; J R Vane
Journal:  Proc Natl Acad Sci U S A       Date:  1988-12       Impact factor: 11.205
  5 in total
  2 in total

1.  Professor Derek Albert Willoughby (1930-2004).

Authors:  K D Rainsford
Journal:  Inflammopharmacology       Date:  2005       Impact factor: 4.473

2.  Endothelin-1 inhibits PAF-induced paw oedema and pleurisy in the mouse.

Authors:  M G Henriques; G A Rae; R S Cordeiro; T J Williams
Journal:  Br J Pharmacol       Date:  1992-07       Impact factor: 8.739
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.